ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Revenue

In the year 2023, ACADIA Pharmaceuticals had annual revenue of $726.44M with 40.45% growth. Revenue in the quarter ending December 31, 2023 was $231.04M with 69.27% year-over-year growth.

• Revenue (ttm): $726.44M
• Revenue Growth: +40.45%
• P/S Ratio: 3.89
• Revenue / Employee: $1,214,778
• Employees: 598
• Market Cap: 2.85B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	726.44M	209.20M	40.45%
Dec 31, 2022	517.24M	33.09M	6.83%
Dec 31, 2021	484.15M	42.39M	9.60%
Dec 31, 2020	441.76M	102.68M	30.28%
Dec 31, 2019	339.08M	115.27M	51.50%
Dec 31, 2018	223.81M	98.91M	79.19%
Dec 31, 2017	124.90M	107.57M	620.68%
Dec 31, 2016	17.33M	17.27M	28,311.48%
Dec 31, 2015	61.00K	-59.00K	-49.17%
Dec 31, 2014	120.00K	-1.03M	-89.52%
Dec 31, 2013	1.15M	-3.76M	-76.67%
Dec 31, 2012	4.91M	2.84M	137.40%
Dec 31, 2011	2.07M	-40.07M	-95.09%
Dec 31, 2010	42.14M	35.74M	558.46%
Dec 31, 2009	6.40M	4.81M	302.45%
Dec 31, 2008	1.59M	-5.97M	-78.95%
Dec 31, 2007	7.56M	-578.00K	-7.11%
Dec 31, 2006	8.13M	-2.82M	-25.77%
Dec 31, 2005	10.96M	6.35M	137.97%
Dec 31, 2004	4.60M	-2.77M	-37.60%
Dec 31, 2003	7.38M	1.10M	17.57%
Dec 31, 2002	6.28M	2.56M	68.98%
Dec 31, 2001	3.71M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.